Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1989-01-03
1991-01-08
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514520, 514522, 514562, 514569, 558412, 558413, 558414, 558415, 558416, 560 10, 560 21, 560 45, 560 46, 560 53, 560 56, 562427, 562428, 562435, 562452, 562462, 562466, A61K 3121
Patent
active
049836285
ABSTRACT:
Compounds having the formula: ##STR1## are antagonists of leukotrienes of C.sub.4, D.sub.4 and E.sub.4, the slow reaction substance of anaphylaxis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.
REFERENCES:
patent: 3954852 (1976-05-01), Shen
patent: 4125732 (1978-11-01), McEvay
patent: 4443626 (1984-04-01), Noda
March, "Advanced Organic Chemistry; Reactions Mechanisms, and Structure," pp. 357-361 (1968).
Bailey, Ann. Rpts. Med Chem., 17, p. 203 (1982).
Samuelson, Science, 220, p. 568 (1983).
Appleton, J. Med. Chem., 20, p. 371 (1977).
Frenette Richard
Kakushima Masatoshi
Rokach Joshua
Young Robert N.
Lopez Gabriel
Merck Frosst Canada Inc.
Pfeiffer Hesna J.
Shippen Michael L.
LandOfFree
Leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-935132